[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, bortezomib is indeed a proteasome inhibitor. Document [1] states that bortezomib is a proteasome inhibitor, and Document [15] also confirms that bortezomib is a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]